Literature DB >> 15664854

1,4-Benzodiazepine-2,5-diones as small molecule antagonists of the HDM2-p53 interaction: discovery and SAR.

Daniel J Parks1, Louis V Lafrance, Raul R Calvo, Karen L Milkiewicz, Varsha Gupta, Jennifer Lattanze, Kannan Ramachandren, Theodore E Carver, Eugene C Petrella, Maxwell D Cummings, Diane Maguire, Bruce L Grasberger, Tianbao Lu.   

Abstract

A library of 1,4-benzodiazepine-2,5-diones was screened for binding to the p53-binding domain of HDM2 using Thermofluor, a miniaturized thermal denaturation assay. The hits obtained were shown to bind to HDM2 in the p53-binding pocket using a fluorescence polarization (FP) peptide displacement assay. The potency of the series was optimized, leading to sub-micromolar antagonists of the p53-HDM2 interaction.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15664854     DOI: 10.1016/j.bmcl.2004.11.009

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  37 in total

Review 1.  Chemistry and biology of multicomponent reactions.

Authors:  Alexander Dömling; Wei Wang; Kan Wang
Journal:  Chem Rev       Date:  2012-03-22       Impact factor: 60.622

2.  Inhibition of MDM2 by RG7388 confers hypersensitivity to X-radiation in xenograft models of childhood sarcoma.

Authors:  Doris Phelps; Kathryn Bondra; Star Seum; Christopher Chronowski; Justin Leasure; Raushan T Kurmasheva; Steven Middleton; Dian Wang; Xiaokui Mo; Peter J Houghton
Journal:  Pediatr Blood Cancer       Date:  2015-04-01       Impact factor: 3.167

3.  Beta-peptides with improved affinity for hDM2 and hDMX.

Authors:  Elizabeth A Harker; Douglas S Daniels; Danielle A Guarracino; Alanna Schepartz
Journal:  Bioorg Med Chem       Date:  2009-01-23       Impact factor: 3.641

4.  A quantitative model of thermal stabilization and destabilization of proteins by ligands.

Authors:  Piotras Cimmperman; Lina Baranauskiene; Simona Jachimoviciūte; Jelena Jachno; Jolanta Torresan; Vilma Michailoviene; Jurgita Matuliene; Jolanta Sereikaite; Vladas Bumelis; Daumantas Matulis
Journal:  Biophys J       Date:  2008-07-03       Impact factor: 4.033

5.  Ligand binding mode prediction by docking: mdm2/mdmx inhibitors as a case study.

Authors:  Nagakumar Bharatham; Kavitha Bharatham; Anang A Shelat; Donald Bashford
Journal:  J Chem Inf Model       Date:  2014-01-21       Impact factor: 4.956

Review 6.  Expanding the number of 'druggable' targets: non-enzymes and protein-protein interactions.

Authors:  Leah N Makley; Jason E Gestwicki
Journal:  Chem Biol Drug Des       Date:  2013-01       Impact factor: 2.817

7.  Structural conservation in band 4.1, ezrin, radixin, moesin (FERM) domains as a guide to identify inhibitors of the proline-rich tyrosine kinase 2.

Authors:  Nathalie Meurice; Lei Wang; Christopher A Lipinski; Zhongbo Yang; Christopher Hulme; Joseph C Loftus
Journal:  J Med Chem       Date:  2010-01-28       Impact factor: 7.446

8.  The p53-MDM2/MDMX axis - A chemotype perspective.

Authors:  Kareem Khoury; Grzegorz M Popowicz; Tad A Holak; Alexander Dömling
Journal:  Medchemcomm       Date:  2011       Impact factor: 3.597

Review 9.  A medicinal chemist's guide to molecular interactions.

Authors:  Caterina Bissantz; Bernd Kuhn; Martin Stahl
Journal:  J Med Chem       Date:  2010-07-22       Impact factor: 7.446

10.  Peptide, Peptidomimetic, and Small-molecule Antagonists of the p53-HDM2 Protein-Protein Interaction.

Authors:  Peter M Fischer
Journal:  Int J Pept Res Ther       Date:  2006-03-15       Impact factor: 1.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.